Facile Rapid Synthesis of Polyaniline (PANI) Nanofibers

A Polyaniline (PANI) nanofibers have been successfully synthesized by a facile rapid oxidative polymerization of aniline hydrochloride and ammonium persulfate at high temperature (60 C). The structural and optical properties of PANI nanofibers are investigated by using X-ray diffraction (XRD), UV-VIS Spectroscopy and Fourier Transform Infrared Spectroscopy (FTIR). The XRD analysis ascertains formation of PANI with nanocrystalline nature with average crystallite size 30 nm. Further, FTIR pattern confirmed the formation of PANI. SEM analysis has revealed homogeneous fibrous morphology of PANI nanofibers, a well formed mesh of interconnected and entangled PANI nano-fibers over the scanned area. The UV-VIS spectroscopic analysis shows three major absorption peaks at 256.73, 361.17 and 480.95 nm confirmed the PANI formation with conducting state

Synthesis of Cuprous Oxide (Cu2O) Nanoparticles – a Review

Cuprous Oxide (Cu2O) a semiconductor material oxide; with unique optoelectronic properties; gains significant importance for its synthesis in view of its various technological and industrial applications. A few liquid phase methods for the synthesis of Cu2O nanoparticles are reviewed on the basis of materials, methodology, synthesis conditions and key findings. A comparative study of these methods is also performed following criteria of repeatability, safety, cost, time span and simplicity. Contextual to the above mentioned criteria, three liquid phase synthesis techniques were shortlisted and actually experimented (as reported) to synthesize the Cu2O nanoparticles. This was done to investigate the effectiveness, repeatability and stability of the synthesized Cu2O product as a function of ageing time. The synthesized Cu2O using all these techniques are prone to be unstable and undergo the rapid phase change to CuO phase which was ascertained from the shift of absorbance peak in UV-VIS spectra. The results have highlighted the urgent need to develop a facile, economical, scalable and safe method to synthesize stable Cu2O nanoparticles at room temperature

Facile Rapid Synthesis of Polyaniline (PANI) Nanofibers

A Polyaniline (PANI) nanofibers have been successfully synthesized by a facile rapid oxidative polymerization of aniline hydrochloride and ammonium persulfate at high temperature (60 C). The structural and optical properties of PANI nanofibers are investigated by using X-ray diffraction (XRD), UV-VIS Spectroscopy and Fourier Transform Infrared Spectroscopy (FTIR). The XRD analysis ascertains formation of PANI with nanocrystalline nature with average crystallite size 30 nm. Further, FTIR pattern confirmed the formation of PANI. SEM analysis has revealed homogeneous fibrous morphology of PANI nanofibers, a well formed mesh of interconnected and entangled PANI nano-fibers over the scanned area. The UV-VIS spectroscopic analysis shows three major absorption peaks at 256.73, 361.17 and 480.95 nm confirmed the PANI formation with conducting state

Phylogenomic identification of five new human homologs of the DNA repair enzyme AlkB

BACKGROUND: Combination of biochemical and bioinformatic analyses led to the discovery of oxidative demethylation – a novel DNA repair mechanism catalyzed by the Escherichia coli AlkB protein and its two human homologs, hABH2 and hABH3. This discovery was based on the prediction made by Aravind and Koonin that AlkB is a member of the 2OG-Fe(2+ )oxygenase superfamily. RESULTS: In this article, we report identification and sequence analysis of five human members of the (2OG-Fe(2+)) oxygenase superfamily designated here as hABH4 through hABH8. These experimentally uncharacterized and poorly annotated genes were not associated with the AlkB family in any database, but are predicted here to be phylogenetically and functionally related to the AlkB family (and specifically to the lineage that groups together hABH2 and hABH3) rather than to any other oxygenase family. Our analysis reveals the history of ABH gene duplications in the evolution of vertebrate genomes. CONCLUSIONS: We hypothesize that hABH 4–8 could either be back-up enzymes for hABH1-3 or may code for novel DNA or RNA repair activities. For example, enzymes that can dealkylate N3-methylpurines or N7-methylpurines in DNA have not been described. Our analysis will guide experimental confirmation of these novel human putative DNA repair enzymes

Synthesis of Cuprous Oxide (Cu2O) Nanoparticles – a Review

Cuprous Oxide (Cu2O) a semiconductor material oxide; with unique optoelectronic properties; gains significant importance for its synthesis in view of its various technological and industrial applications. A few liquid phase methods for the synthesis of Cu2O nanoparticles are reviewed on the basis of materials, methodology, synthesis conditions and key findings. A comparative study of these methods is also performed following criteria of repeatability, safety, cost, time span and simplicity. Contextual to the above mentioned criteria, three liquid phase synthesis techniques were shortlisted and actually experimented (as reported) to synthesize the Cu2O nanoparticles. This was done to investigate the effectiveness, repeatability and stability of the synthesized Cu2O product as a function of ageing time. The synthesized Cu2O using all these techniques are prone to be unstable and undergo the rapid phase change to CuO phase which was ascertained from the shift of absorbance peak in UV-VIS spectra. The results have highlighted the urgent need to develop a facile, economical, scalable and safe method to synthesize stable Cu2O nanoparticles at room temperature

Anaerobic metabolism in Lake Washington sediments

A method of measuring the dehydrogenase activity of sediments at lOC was calibrated by direct microcalorimetry at the same temperature. Field measurements of dehydrogenase activity of sediments in Lake Washington were converted to rates of metabolic heat release by means of the significant regression of dehydrogenase activity on metabolic heat release. Simultaneous field measurements at IOC of oxygen uptake by undistrubed sediment cores were coverted to rates of metabolic heat release by the factor 4.8 cal liberated per milliliter of oxygen consumed. Dehydrogenase activity varies from place to place and differs between layers of the same core. Although there is a general trend of decreasing activity with sediment depth, some subsurface layers have relatively high activity. Dehydrogenase activity, which was detected down to the deepest layers of the sediment cores, 21 to 31 cm, appears to be more a function of plankton remains than of total organic carbon in the sediment. The integrated metabolic heat release based on dehydrogenase activity of the entire core was invariably greater than the metabolic heat release calculated from the rates of oxygen uptake. Thus, it appears that the rate of total oxygen uptake by the sediment surface underestimates benthic community metabolism in the sediment column

A nomenclature for restriction enzymes, DNA methyltransferases, homing endonucleases and their genes

A nomenclature is described for restriction endonucleases, DNA methyltransferases, homing endonucleases and related genes and gene products. It provides explicit categories for the many different Type II enzymes now identified and provides a system for naming the putative genes found by sequence analysis of microbial genome

The COMBREX Project: Design, Methodology, and Initial Results

© 2013 Brian P. et al.Prior to the “genomic era,” when the acquisition of DNA sequence involved significant labor and expense, the sequencing of genes was strongly linked to the experimental characterization of their products. Sequencing at that time directly resulted from the need to understand an experimentally determined phenotype or biochemical activity. Now that DNA sequencing has become orders of magnitude faster and less expensive, focus has shifted to sequencing entire genomes. Since biochemistry and genetics have not, by and large, enjoyed the same improvement of scale, public sequence repositories now predominantly contain putative protein sequences for which there is no direct experimental evidence of function. Computational approaches attempt to leverage evidence associated with the ever-smaller fraction of experimentally analyzed proteins to predict function for these putative proteins. Maximizing our understanding of function over the universe of proteins in toto requires not only robust computational methods of inference but also a judicious allocation of experimental resources, focusing on proteins whose experimental characterization will maximize the number and accuracy of follow-on predictions.COMBREX is funded by a GO grant from the National Institute of General Medical Sciences (NIGMS) (1RC2GM092602-01).Peer Reviewe

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Background: Glucagon-like peptide 1 receptor agonists differ in chemical structure, duration of action, and in their effects on clinical outcomes. The cardiovascular effects of once-weekly albiglutide in type 2 diabetes are unknown. We aimed to determine the safety and efficacy of albiglutide in preventing cardiovascular death, myocardial infarction, or stroke. Methods: We did a double-blind, randomised, placebo-controlled trial in 610 sites across 28 countries. We randomly assigned patients aged 40 years and older with type 2 diabetes and cardiovascular disease (at a 1:1 ratio) to groups that either received a subcutaneous injection of albiglutide (30–50 mg, based on glycaemic response and tolerability) or of a matched volume of placebo once a week, in addition to their standard care. Investigators used an interactive voice or web response system to obtain treatment assignment, and patients and all study investigators were masked to their treatment allocation. We hypothesised that albiglutide would be non-inferior to placebo for the primary outcome of the first occurrence of cardiovascular death, myocardial infarction, or stroke, which was assessed in the intention-to-treat population. If non-inferiority was confirmed by an upper limit of the 95% CI for a hazard ratio of less than 1·30, closed testing for superiority was prespecified. This study is registered with ClinicalTrials.gov, number NCT02465515. Findings: Patients were screened between July 1, 2015, and Nov 24, 2016. 10 793 patients were screened and 9463 participants were enrolled and randomly assigned to groups: 4731 patients were assigned to receive albiglutide and 4732 patients to receive placebo. On Nov 8, 2017, it was determined that 611 primary endpoints and a median follow-up of at least 1·5 years had accrued, and participants returned for a final visit and discontinuation from study treatment; the last patient visit was on March 12, 2018. These 9463 patients, the intention-to-treat population, were evaluated for a median duration of 1·6 years and were assessed for the primary outcome. The primary composite outcome occurred in 338 (7%) of 4731 patients at an incidence rate of 4·6 events per 100 person-years in the albiglutide group and in 428 (9%) of 4732 patients at an incidence rate of 5·9 events per 100 person-years in the placebo group (hazard ratio 0·78, 95% CI 0·68–0·90), which indicated that albiglutide was superior to placebo (p<0·0001 for non-inferiority; p=0·0006 for superiority). The incidence of acute pancreatitis (ten patients in the albiglutide group and seven patients in the placebo group), pancreatic cancer (six patients in the albiglutide group and five patients in the placebo group), medullary thyroid carcinoma (zero patients in both groups), and other serious adverse events did not differ between the two groups. There were three (<1%) deaths in the placebo group that were assessed by investigators, who were masked to study drug assignment, to be treatment-related and two (<1%) deaths in the albiglutide group. Interpretation: In patients with type 2 diabetes and cardiovascular disease, albiglutide was superior to placebo with respect to major adverse cardiovascular events. Evidence-based glucagon-like peptide 1 receptor agonists should therefore be considered as part of a comprehensive strategy to reduce the risk of cardiovascular events in patients with type 2 diabetes. Funding: GlaxoSmithKline

Novel Facile Technique for Synthesis of Stable Cuprous Oxide (Cu2O) Nanoparticles – an Ageing Effect

A novel facile method to synthesize stable phase of Cuprous Oxide (Cu2O) nanoparticles at room temperature is demonstrated. The structural and optical properties of (Cu2O) nanoparticles were investigated by using X-ray diffraction (XRD), UV-VIS Spectroscopy. XRD analysis has indexed nanocrystalline nature of cubical phase Cu2O with an average edge length of about 20 nm. The Scanning Electron Microscopy (SEM) measurements also ascertain the cubical morphology. The Fourier Transform Infrared Spectroscopy (FTIR) affirms the presence of characteristic functional group of Cu2O. The absorbance peak at 485 nm in UV-VIS spectra also confirms the Cu2O synthesis. Furthermore, UV-VIS absorbance spectra at different ageing time substantiate the phase stability of Cu2O nanoparticles. The ageing leads to blue shift of absorbance peak mainly due to decrease in Cu2O particle size with no additional absorbance peak in UV-VIS spectra indicating the formation of secondary phase. The reduction in particle size may be attributed to tiny conversion Cu2O to CuO. The energy band gap measurements from Tauc plots for Cu2O nanoparticles shows the increasing trend (2.5 eV to 2.8 eV) with ageing time (2 months), owing to quantum confinement effects